Summary
58 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Out of every 100 SEK of revenue, 11 SEK is left as free cash.
What to watch
- Earnings per share fell by 9.3% a year over the last 3 years.
- It missed profit estimates 5 times in the last 8 quarters.
- Out of every 100 SEK of revenue, only 3.5 SEK is left as net profit.
- It earns only 3.5 SEK a year on every 100 SEK of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 20.6 SEK for 1 SEK of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (SEK)
Diluted EPS (SEK)
- Analyst estimate
Revenue grew by 3.9% a year over 5 years. Over the last 3 years it grew by 3.3% a year. For the next fiscal year analysts expect revenue to grow by 3.3%. Earnings per share fell by 9.3% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 SEK of revenue goes
- Cost of sales 60 SEK
- Research and development 1.2 SEK
- Sales and administration 31 SEK
- Taxes and other 4.1 SEK
- Net profit 3.3 SEK
Net profit, industry median (Medical - Distribution) 1.4 SEK
Out of every 100 SEK of revenue, 3.3 SEK is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 4.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 3.54%
- Paid out of profit
- 73%
- Raised in a row
- 1 year
You receive $0.10 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 1
- Hold 2
- Sell 0
No analyst has published a price target.
33% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.